Comments

CytoMed Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does CytoMed Therapeutics (GDTC) operate in?

CytoMed Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GDTCNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.05

At close: Jun 5, 5:55 PM EDT

$2.01

-0.04-1.90%

Pre-Market: Jun 5, 5:55 PM EDT

CytoMed Therapeutics (GDTC) Forecast

News Earnings CytoMed Therapeutics (GDTC) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

CytoMed Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:GDTC | Benzinga

Explore CytoMed Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GDTC.

Open	-
Close	-
Volume / Avg.	0 / 17.88K
Day Range	- - -
52 Wk Range	1.20 - 4.05
Market Cap	$23.21M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	2.23%
Days to Cover	12.23

Recent News

Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor

CytoMed Therapeutics teams with SunAct for a Phase 1/2 trial on gamma delta T cells in cancer therapy, advancing affordable immunotherapy solutions.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 17.88K
Day Range	- - -
52 Wk Range	1.20 - 4.05
Market Cap	$23.21M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	2.23%
Days to Cover	12.23

About CytoMed Therapeutics Ltd

Sector

Health Care

Industry

Biotechnology

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its propr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CytoMed Therapeutics (GDTC) stock?

You can purchase shares of CytoMed Therapeutics (NASDAQ:GDTC) through any online brokerage.

View our list of the best stock brokerages

Who are CytoMed Therapeutics (GDTC) competitors?

Other companies in CytoMed Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Imunon (NASDAQ:IMNN), Curis (NASDAQ:CRIS), Evaxion (NASDAQ:EVAX) and Nanoviricides (AMEX:NNVC).

What is the forecast, or price target, for CytoMed Therapeutics (GDTC) stock?

CytoMed Therapeutics has a consensus price target of $5.00.

What is the current price for CytoMed Therapeutics (GDTC)?

The stock price for CytoMed Therapeutics (NASDAQ: GDTC) is $2.0111 last updated June 5, 2025 at 5:55 PM EDT.

Does CytoMed Therapeutics (GDTC) pay a dividend?

There are no upcoming dividends for CytoMed Therapeutics.

When is CytoMed Therapeutics (NASDAQ:GDTC) reporting earnings?

CytoMed Therapeutics does not have any upcoming earnings scheduled.

Is CytoMed Therapeutics (GDTC) going to split?

There is no upcoming split for CytoMed Therapeutics.

What sector and industry does CytoMed Therapeutics (GDTC) operate in?

CytoMed Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.